Image (B1e7ffe5 7d5f 4e02 A9c9 3d9ad3fac23e 01)
Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 70069-044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 70069-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (B1e7ffe5 7d5f 4e02 A9c9 3d9ad3fac23e 02)
This text provides data on the estimated proportion of patients experiencing treatment failure over a range of days from randomization. The comparison is between Clonidine HCI and Placebo. The chart shows the progression of treatment failure over time.*
Desc (B1e7ffe5 7d5f 4e02 A9c9 3d9ad3fac23e 03)
This text contains information about Clonidine Hydrochloride Extended-Release Tablets, each containing 0.1 mg of Clonidine Hydrochloride. The tablets are to be swallowed whole and must not be crushed, cut, or chewed. It is recommended to store the tablets at a temperature between 20°C to 25°C and avoid temperatures outside the range of 15°C to 30°C. The tablets are dispensed in a tight container as specified in the USP. The manufacturer is Somerset Therapeutics LLC, and they are made in Portugal. This medication is prescription only.*
Image (B1e7ffe5 7d5f 4e02 A9c9 3d9ad3fac23e 106 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
